High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal women

Journal of Clinical Lipidology

Volumn 3, Issue 5, 2009, Pages 345-350

  Keidar, Shlomo ^a,b   Bogner, Ido ^b   Gamliel Lazarovich, Aviva ^a   Leiba, Ronit ^b   Fuhrman, Bianca ^a   Kouperberg, Efim ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Carotid; FRS; HDL

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 70349796457     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.08.003     Document Type: Article

References (29)

1. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
3. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
4. Law M.R., Wald N.J., and Morris J.K. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen 11 (2004) 3-7
5. Michos E.D., Nasir K., Braunstein J.B., et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis 184 (2006) 201-206
6. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256 (1986) 2835-2838
7. Shah P.K., Kaul S., Nilsson J., and Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 104 (2001) 2376-2383
8. Navab M., Van Lenten B.J., Reddy S.T., and Fogelman A.M. High-density lipoprotein and the dynamics of atherosclerotic lesions. Circulation 104 (2001) 2386-2387
9. Amarenco P., Labreuche J., and Touboul P.J. High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis 196 (2008) 489-496
10. Bittner V., Simon J.A., Fong J., Blumenthal R.S., Newby K., and Stefanick M.L. Correlates of high HDL cholesterol among women with coronary heart disease. Am Heart J 139 (2000) 288-296
11. van der Steeg W.A., Holme I., Boekholdt S.M., et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol 51 (2008) 634-642
12. Grant E.G., Benson C.B., Moneta G.L., et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 229 (2003) 340-346
13. European Carotid Plaque Study Group. Carotid artery plaque composition - Relationship to clinical presentation and ultrasound B-mode imaging. Eur J Vasc Endovasc Surg 10 (1995) 23-30
14. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
15. Nauck M., Warnick G.R., and Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 48 (2002) 236-254
16. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med 30 (1983) 111-118
17. Gan K.N., Smolen A., Eckerson H.W., and La Du B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19 (1991) 100-106
18. Rosenblat M., Vaya J., Shih D., and Aviram M. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis 179 (2005) 69-77
19. Navab M., Reddy S.T., Van Lenten B.J., Anantharamaiah G.M., and Fogelman A.M. The role of dysfunctional HDL in atherosclerosis. J Lipid Res 50 Suppl (2009) S145-X149
20. Dodani S., GriceD G., and Joshi S. Is HDL function as important as HDL quantity in the coronary artery risk assessment?. J Clin Lipidol 3 (2009) 70-77
21. Rader D.J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 116 (2006) 3090-3100
22. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
23. Simon A., Chironi G., and Levenson J. Performance of subclinical arterial disease detection as a screening test for coronary heart disease. Hypertension 48 (2006) 392-396
24. Simon A., Chironi G., and Levenson J. Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J 28 (2007) 2967-2971
25. Johnsen S.H., Mathiesen E.B., Joakimsen O., et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study. Stroke 38 (2007) 2873-2880
26. Hegele R.A. The pathogenesis of atherosclerosis. Clin Chim Acta 246 (1996) 21-38
27. Tall A.R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 263 (2008) 256-273
28. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23 (2003) 712-719
29. Duong M., Collins H.L., Jin W., Zanotti I., Favari E., and Rothblat G.H. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 26 (2006) 541-547